Rapid Structure-Activity and Selectivity Analysis of Kinase Inhibitors by BioMAP Analysis in Complex Human Primary Cell-Based Models
Eric J. Kunkel, Ellen L. Berg(Pulse Biosciences (United States)), Dat Nguyen(Exelixis (United States)), Elen Rosler(Collaborative Drug Discovery (United States)), Eugene C. Butcher(VA Palo Alto Health Care System), Jennifer Melrose(Collaborative Drug Discovery (United States)), Leon T. Kao(Collaborative Drug Discovery (United States)), Ivan Plavec(Genesys (United States)), Anthony C. Bishop(Amherst College), Kevan M. Shokat(Howard Hughes Medical Institute), Yuker Wang(Collaborative Drug Discovery (United States)), Raynard L. Bateman, Evangelos Hytopoulos(Collaborative Drug Discovery (United States))
Cited by 82
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k